NovoLog PenFill and Trastuzumab and Hyaluronidase
Determining the interaction of NovoLog PenFill and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog PenFill-Trastuzumab Injection (Intravenous)
- NovoLog PenFill-Trastuzumab Intravenous
- NovoLog PenFill-Trastuzumab-anns
- NovoLog PenFill-Trastuzumab-dkst
- NovoLog PenFill-Trastuzumab-dkst Intravenous
- NovoLog PenFill-Trasylol
- Trastuzumab and Hyaluronidase-Novoseven
- Trastuzumab and Hyaluronidase-NovoSeven RT
- Trastuzumab and Hyaluronidase-NovoSeven RT with MixPro injection
- Trastuzumab and Hyaluronidase-Novothyrox
- Trastuzumab and Hyaluronidase-Noxafil
- Trastuzumab and Hyaluronidase-Noxafil (Posaconazole Delayed-Release Tablets)